Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa
- 1 November 1988
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 22 (5) , 729-738
- https://doi.org/10.1093/jac/22.5.729
Abstract
Gastric mucosal concentrations of erythromycin, amoxycillin, ampicillin and ciprofloxacin were determined in patients at upper gastrointestinal endoscopy 38–480 min after a 500 mg dose of erythromycin ethyl succinate, erythromycin stearate, amoxycillin, pivampicillin or ciprofloxacin. All the agents attained concentrations greater than the MIC 90 for Campylobacter pylori. The macrolides attained the lowest concentrations. There was no significant difference between concentrations attained with erythromycin ethyl succinate and stearate. High concentrations were attained by amoxycillin (range 14.6–322 mg/kg) and pivampicillin (range 47.5–209 mg/kg). Ciprofloxacin attained very high concentrations (range 35–1762 mg–kg); inhibitory concentrations 35 mg/kg) were still present at 6 h after the dose. Ciprofloxacin and erythromycin are ineffective in vivo despite these high gastric mucosal concentrations. Penetration into the gastric mucus and crypts where C. pylori is found will be determined by physicochemical properties of the antimicrobials, such as pKa, stability, activity over a wide range of pH, and lipid solubility.Keywords
This publication has 8 references indexed in Scilit:
- Campylobacter pyloridis-associated chronic active antral gastritisGastroenterology, 1988
- CAMPYLOBACTER PYLORI AND RECURRENCE OF DUODENAL ULCERS— A 12-MONTH FOLLOW-UP STUDYThe Lancet, 1987
- pH of the microclimate lining human gastric and duodenal mucosa in vivoGastroenterology, 1987
- INGESTION OF CAMPYLOBACTER-PYLORIDIS CAUSES GASTRITIS AND RAISED FASTING GASTRIC PH1987
- Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate.BMJ, 1986
- Identification of Campylobacter pyloridis isolates by restriction endonuclease DNA analysisJournal of Clinical Microbiology, 1986
- Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1985
- SITE OF ABSORPTION OF ERYTHROMYCIN IN RATS1954